peru-15-pctb
Vaccineexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2008 (NCT00654108)
Timeline
Indications
Mechanism of action
- Vibrio choleraeImmunity, active
Vibrio cholerae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- peru-15-pctb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00624975 | Phase 2 | Nov 1, 2008 | Avant Immunotherapeutics, Christian Medical College, Vellore, India, International Center for Diarrheal Disease Research, International Vaccine Institute, Vaccine Technologies Inc. |
| NCT00654108 | Phase 1 | Jun 1, 2008 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Avant Immunotherapeutics | For profit | 1 | 0 | 1 | 2008 |
| Christian Medical College, Vellore, India | Academic/Hospital | 1 | 0 | 1 | 2008 |
| International Center for Diarrheal Disease Research | Academic/Hospital | 1 | 0 | 1 | 2008 |
| International Vaccine Institute | Academic/Hospital | 1 | 1 | 1 | 2008 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2008 |
| Vaccine Technologies Inc. | For profit | 1 | 0 | 1 | 2008 |
6 organizations
Page 1 / 1